Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mark S Riddle

Showing results (201-210 of 221) with videos related to

Pageof 23
Sort By:
Plos One|August 14, 2020
Epidemiology and associated microbiota changes in deployed military personnel at high risk of traveler's diarrheaWilliam A Walters, Faviola Reyes, Giselle M Soto, et al.
Gastroenterology|March 14, 2020
Serum Biomarkers Identify Patients Who Will Develop Inflammatory Bowel Diseases Up to 5 Years Before DiagnosisJoana Torres, Francesca Petralia, Takahiro Sato, et al.
Plos One|December 2, 2020
Refinement of the CS6-expressing enterotoxigenic Escherichia coli strain B7A human challenge model: A randomized trialKawsar R Talaat, Chad K Porter, Kayla M Jaep, et al.
Vaccine|September 26, 2020
A first in human clinical trial assessing the safety and immunogenicity of transcutaneously delivered enterotoxigenic Escherichia coli fimbrial tip adhesin with heat-labile enterotoxin with mutation R192GMark S Riddle, Milton Maciel, Chad K Porter, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|July 11, 2013
Lack of homologous protection against Campylobacter jejuni CG8421 in a human challenge modelBeth D Kirkpatrick, Caroline E Lyon, Chad K Porter, et al.
Vaccine|July 27, 2011
Safety and immunogenicity of an intranasal Shigella flexneri 2a Invaplex 50 vaccineMark S Riddle, Robert W Kaminski, Carlos Williams, et al.
Proceedings of the National Academy of Sciences of the United States of America|August 22, 2018
Enterotoxigenic <i>E. coli</i> virulence gene regulation in human infectionsAlexander A Crofts, Simone M Giovanetti, Erica J Rubin, et al.
Ebiomedicine|April 4, 2021
Immune response characterization in a human challenge study with a Shigella flexneri 2a bioconjugate vaccineKristen A Clarkson, Kawsar R Talaat, Cristina Alaimo, et al.
Mbio|December 12, 2023
Gut microbiome and antibiotic resistance effects during travelers' diarrhea treatment and preventionKevin S Blake, Drew J Schwartz, Srinand Paruthiyil, et al.
Vaccine|November 28, 2021
World Health Organization Expert Working Group: Recommendations for assessing morbidity associated with enteric pathogensMateusz Hasso-Agopsowicz, Benjamin A Lopman, Claudio F Lanata, et al.
Pageof 23

Showing results (201-210 of 221) with videos related to

Sort By:
Pageof 23
Plos One|August 14, 2020
Epidemiology and associated microbiota changes in deployed military personnel at high risk of traveler's diarrheaWilliam A Walters, Faviola Reyes, Giselle M Soto, et al.
Gastroenterology|March 14, 2020
Serum Biomarkers Identify Patients Who Will Develop Inflammatory Bowel Diseases Up to 5 Years Before DiagnosisJoana Torres, Francesca Petralia, Takahiro Sato, et al.
Plos One|December 2, 2020
Refinement of the CS6-expressing enterotoxigenic Escherichia coli strain B7A human challenge model: A randomized trialKawsar R Talaat, Chad K Porter, Kayla M Jaep, et al.
Vaccine|September 26, 2020
A first in human clinical trial assessing the safety and immunogenicity of transcutaneously delivered enterotoxigenic Escherichia coli fimbrial tip adhesin with heat-labile enterotoxin with mutation R192GMark S Riddle, Milton Maciel, Chad K Porter, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|July 11, 2013
Lack of homologous protection against Campylobacter jejuni CG8421 in a human challenge modelBeth D Kirkpatrick, Caroline E Lyon, Chad K Porter, et al.
Vaccine|July 27, 2011
Safety and immunogenicity of an intranasal Shigella flexneri 2a Invaplex 50 vaccineMark S Riddle, Robert W Kaminski, Carlos Williams, et al.
Proceedings of the National Academy of Sciences of the United States of America|August 22, 2018
Enterotoxigenic <i>E. coli</i> virulence gene regulation in human infectionsAlexander A Crofts, Simone M Giovanetti, Erica J Rubin, et al.
Ebiomedicine|April 4, 2021
Immune response characterization in a human challenge study with a Shigella flexneri 2a bioconjugate vaccineKristen A Clarkson, Kawsar R Talaat, Cristina Alaimo, et al.
Mbio|December 12, 2023
Gut microbiome and antibiotic resistance effects during travelers' diarrhea treatment and preventionKevin S Blake, Drew J Schwartz, Srinand Paruthiyil, et al.
Vaccine|November 28, 2021
World Health Organization Expert Working Group: Recommendations for assessing morbidity associated with enteric pathogensMateusz Hasso-Agopsowicz, Benjamin A Lopman, Claudio F Lanata, et al.
Pageof 23